Literature DB >> 32002787

Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons.

Manuela Loi1, Stefania Trazzi2, Claudia Fuchs1, Giuseppe Galvani1, Giorgio Medici1, Laura Gennaccaro1, Marianna Tassinari1, Elisabetta Ciani3.   

Abstract

Mutations in the CDKL5 gene, which encodes a serine/threonine kinase, causes a rare encephalopathy, characterized by early-onset epilepsy and severe intellectual disability, named CDKL5 deficiency disorder (CDD). In vitro and in vivo studies in mouse models of Cdkl5 deficiency have highlighted the role of CDKL5 in brain development and, in particular, in the morphogenesis and synaptic connectivity of hippocampal and cortical neurons. Interestingly, Cdkl5 deficiency in mice increases vulnerability to excitotoxic stress in hippocampal neurons. However, the mechanism by which CDKL5 controls neuronal survival is far from being understood. To investigate further the function of CDKL5 and dissect the molecular mechanisms underlying neuronal survival, we generated a human neuronal model of CDKL5 deficiency, using CRISPR/Cas9-mediated genome editing. We demonstrated that CDKL5 deletion in human neuroblastoma SH-SY5Y cells not only impairs neuronal maturation but also reduces cell proliferation and survival, with alterations in the AKT and ERK signaling pathways and an increase in the proapoptotic BAX protein and in DNA damage-associated biomarkers (i.e., γH2AX, RAD50, and PARP1). Furthermore, CDKL5-deficient cells were hypersensitive to DNA damage-associated stress, accumulated more DNA damage foci (γH2AX positive) and were more prone to cell death than the controls. Importantly, increased kainic acid-induced cell death of hippocampal neurons of Cdkl5 KO mice correlated with an increased γH2AX immunostaining. The results suggest a previously unknown role for CDKL5 in DNA damage response that could underlie the pro-survival function of CDKL5.

Entities:  

Keywords:  CDKL5; DNA damage; Neuronal maturation; Oxidative stress; γH2AX

Mesh:

Substances:

Year:  2020        PMID: 32002787     DOI: 10.1007/s12035-020-01884-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  48 in total

1.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

Review 2.  Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder.

Authors:  Tristan Dale; Jenny Downs; Heather Olson; Ann Marie Bergin; Stephanie Smith; Helen Leonard
Journal:  Epilepsy Res       Date:  2019-02-05       Impact factor: 3.045

3.  Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy.

Authors:  Jana Neupauerová; Katalin Štěrbová; Markéta Vlčková; Věra Sebroňová; Tat'ána Maříková; Marcela Krůtová; Staněk David; Pavel Kršek; Markéta Žaliová; Pavel Seeman; Petra Laššuthová
Journal:  Genet Test Mol Biomarkers       Date:  2017-09-05

4.  Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.

Authors:  Stephanie Fehr; Kingsley Wong; Richard Chin; Simon Williams; Nick de Klerk; David Forbes; Rahul Krishnaraj; John Christodoulou; Jenny Downs; Helen Leonard
Journal:  Neurology       Date:  2016-10-21       Impact factor: 9.910

5.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

6.  Functional abilities in children and adults with the CDKL5 disorder.

Authors:  Stephanie Fehr; Jenny Downs; Gladys Ho; Nick de Klerk; David Forbes; John Christodoulou; Simon Williams; Helen Leonard
Journal:  Am J Med Genet A       Date:  2016-08-16       Impact factor: 2.802

7.  CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.

Authors:  Laura Rusconi; Lisa Salvatoni; Laura Giudici; Ilaria Bertani; Charlotte Kilstrup-Nielsen; Vania Broccoli; Nicoletta Landsberger
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

8.  CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders.

Authors:  Clark Lin; Brunella Franco; Marsha Rich Rosner
Journal:  Hum Mol Genet       Date:  2005-12-05       Impact factor: 6.150

Review 9.  What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy.

Authors:  Charlotte Kilstrup-Nielsen; Laura Rusconi; Paolo La Montanara; Dalila Ciceri; Anna Bergo; Francesco Bedogni; Nicoletta Landsberger
Journal:  Neural Plast       Date:  2012-06-17       Impact factor: 3.599

10.  Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region.

Authors:  E Montini; G Andolfi; A Caruso; G Buchner; S M Walpole; M Mariani; G Consalez; D Trump; A Ballabio; B Franco
Journal:  Genomics       Date:  1998-08-01       Impact factor: 5.736

View more
  7 in total

1.  A Novel Methodology Using Dexamethasone to Induce Neuronal Differentiation in the CNS-Derived Catecholaminergic CAD Cells.

Authors:  Ekkaphot Khongkla; Kwanchanok Uppakara; Nittaya Boonmuen; Kanit Bhukhai; Witchuda Saengsawang
Journal:  Cell Mol Neurobiol       Date:  2021-05-31       Impact factor: 4.231

Review 2.  Oxidative Stress Evaluation in Ischemia Reperfusion Models: Characteristics, Limits and Perspectives.

Authors:  Pauline Chazelas; Clara Steichen; Frédéric Favreau; Patrick Trouillas; Patrick Hannaert; Raphaël Thuillier; Sébastien Giraud; Thierry Hauet; Jérôme Guillard
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

3.  Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder.

Authors:  Marianna Tassinari; Nicola Mottolese; Giuseppe Galvani; Domenico Ferrara; Laura Gennaccaro; Manuela Loi; Giorgio Medici; Giulia Candini; Roberto Rimondini; Elisabetta Ciani; Stefania Trazzi
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

Review 4.  CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.

Authors:  Nicole J Van Bergen; Sean Massey; Anita Quigley; Ben Rollo; Alexander R Harris; Robert M I Kapsa; John Christodoulou
Journal:  Biochem Soc Trans       Date:  2022-08-31       Impact factor: 4.919

5.  Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder.

Authors:  Manuela Loi; Laura Gennaccaro; Claudia Fuchs; Stefania Trazzi; Giorgio Medici; Giuseppe Galvani; Nicola Mottolese; Marianna Tassinari; Roberto Rimondini Giorgini; Andrea Milelli; Elisabetta Ciani
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

6.  Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death.

Authors:  Laura Gennaccaro; Claudia Fuchs; Manuela Loi; Riccardo Pizzo; Sara Alvente; Chiara Berteotti; Leonardo Lupori; Giulia Sagona; Giuseppe Galvani; Antonia Gurgone; Alessandra Raspanti; Giorgio Medici; Marianna Tassinari; Stefania Trazzi; Elisa Ren; Roberto Rimondini; Tommaso Pizzorusso; Giovanna Zoccoli; Maurizio Giustetto; Elisabetta Ciani
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

7.  Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.

Authors:  Giuseppe Galvani; Nicola Mottolese; Laura Gennaccaro; Manuela Loi; Giorgio Medici; Marianna Tassinari; Claudia Fuchs; Elisabetta Ciani; Stefania Trazzi
Journal:  J Neuroinflammation       Date:  2021-07-08       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.